Recruiting NCT06637644
Impella RP Flex with Smart Assist
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Right-sided ventricular assist device.
- Who it may be relevant to
- Registry conditions: Right Ventricular (RV) Dysfunction. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impella RP Flex Registry
Overview
To capture observational data of the Abiomed Impella RP Flex in a real-world setting.
Interventions
- Device Right-sided ventricular assist device
Percutaneous device for right heart support
Primary outcome measures
- Objectives [Time frame: 1 year post implant]
Eligibility criteria
Inclusion criteria
- Subjects who received mechanical circulatory support (MCS) with an Impella RP Flex will be considered eligible for the registry.
Exclusion criteria
- None
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 31 centers
- University of Alabama at Birmingham — Birmingham
- Pima Heart and Vascular — Tucson
- Baptist Health Heart Failure and Transplant Institute — Little Rock
- Arkansas Heart Hospital — Little Rock
- University of Southern California (Keck USC) — Los Angeles
- Advent Health Orlando — Orlando
- Tampa General — Tampa
- Ochsner Clinic Foundation — New Orleans
- … and 23 more centers
Identifiers
NCT: NCT06637644 · Impella RP Flex Study